Compare Senores Pharma and Ventive IPOs for potential listing gains. Discover which could deliver better returns!

Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock ...

According to market observers, the grey market is expecting that Senores Pharmaceuticals IPO listing price would be around ...

Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock ...

The Rs 582.1-crore Senores Pharmaceuticals offering consists of a fresh issue of Rs 500 crore and an offer for sale of Rs ...

Shares of Senores Pharmaceuticals are scheduled to be listed on the stock exchanges today on Monday, December 30, following a ...

Senores Pharma shares listed at Rs 593.70 apiece on the BSE, reflecting a premium of 51.84 per cent over the IPO allotment ...

Shares of Senores Pharmaceuticals Limited made a healthy debut on the exchange to list at a 53.45% premium. The scrip listed Rs 593.70 per share on BSE, a premium of 51.84% and Rs 600 per share on NSE ...

Carraro India, Senores Pharmaceuticals, and Ventive Hospitality will list on Monday, along with Unimech Aerospace and ...

Senores Pharmaceuticals IPO share allotment will be finalized soon, with investors able to check their status via BSE or the ...

Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.

Ahmedabad-based Senores Pharmaceuticals raised Rs 582.11 crore through its IPO, which comprised a fresh issue of Rs 500 crore and an offer-for-sale of Rs 82.11 crore.